Objectives. Stroke is a major cause of brain injury in Alaska. Since antioxidant levels are decreased in aged brain, the greater predisposition to neuronal death in stroke leading to subsequent neurodegeneration in aged individuals may be related to changes in oxidant balance. We studied the effect of the endogenous antioxidant melatonin on excitotoxic injury resulting from N-methyl-D-aspartate (NMDA)-induced damage by developing an organotypic mouse brain slice model. Our objective was to inhibit the effects of oxidative stress induced by NMDA in mouse brain slices, using melatonin. Methods. An organotypic mouse brain slice culture was established at PO 2 levels maintained between 80 -100 mm Hg. NMDA, melatonin or both were added to the slices and antioxidant function was determined using the redox active iron assay as well as 8-OHG and HO-1 immunoassays. Results. This slice system allows for better regulation of both NMDA and melatonin concentrations than can be achieved by in vivo studies. Supporting an antioxidant function, melatonin (100 µM) significantly decreased redox active iron, heme-oxygenase (HO-1) induction and 8-hydroxyguanosine (8-OHG) following NMDA (50-100 µM) insult. However, somewhat surprisingly, high concentrations of melatonin alone (1mM), increased redox active iron levels and HO-1 induction. Conclusions. These results support the hypothesis that melatonin is a neuroprotective antioxidant. Our data also suggest that 1mM melatonin may have detrimental effects. (Int J Circumpolar Health 2002; 61: 32-40) 
hormones, are linked to this high incidence of stroke. Stroke causes cell trauma at the point of infarct due to loss of blood flow. Acute injury at the initial infarct site during stroke causes cells to swell, lyse and leak intracellular contents, including glutamate, into extracellular space (Love, 1999) . The resulting increase in the extracellular glutamate levels causes secondary excitotoxic damage to surrounding cells via chronic glutamate receptor overstimulation (Babu and Bawari, 1997; Choi, 1992; Olney et al., 1986; Didier et al., 1996) . The N-methyl-D-asparate (NMDA) receptor is a glutamate-gated calcium channel which, when over stimulated following ischemia, causes disruption of intracellular Ca 2+ homeostasis (Chan, 1992) . Elevated Ca 2+ levels can induce oxidative stress via the production of free radicals by several mechanisms including mitochondrial energy disruption (Mattson et al., 1997) , proteolytic breakdown of proteins (Stadtman and Berlett, 1997 ) and the catalysis of reactions such as the conversion of xanthine dehydrogense to xanthine oxidase (Dykens et al., 1987) . Antioxidants and free radical scavengers, such as ascorbate, may be protective as seen in experimental models of stroke and excitotoxicity (Brahma et al., 2000; Kim and Kwon, 1999; Joo et al, 1998) . Over the last few years, melatonin has attracted attention as a possible therapeutic agent for stroke and Alzheimer's disease patients (Reiter et al., 1999) .
Melatonin, an endogenous antioxidant, prevents oxidative damage and protects primary cell cultures from NMDA insult (Cazevieille et al., 1997; Guisti et al., 1995) . In vivo ischemia models in rat demonstrated that melatonin prevents reactive oxygen species (ROS)-induced lipid and DNA damage Uz et al, 1996; Wakatsuki et al., 1999) . Melatonin is able to scavenge hydroxyl radicals, which are elevated in the aged brain, since superoxide dismutase gene expression and activity are increased (Poeggeler et al., 1993) . Neuroprotection by melatonin in an in vivo model of stroke has also been shown by Joo et al (1998) .
Although plasma melatonin concentrations fluctuate dramatically according to a circadian cycle (Levine et al., 1994; Skene et al., 1990) , melatonin is thought to have a wide margin of safety and has been administered in doses as high as 14mg/kg/day for up to 30 days (Nordlund and Lerner, 1977) . To test the effects of 100µM and 1mM melatonin on NMDA-induced oxidative stress and cell death using, for the first time, an organotypic mouse brain-slice preparation, we performed an initial qualitative morphological analysis of tissue ultrastructure, followed by quantitative biochemical assays for markers of oxidative stress (Smith et al., 1997; Smith et al., 1998) .
MATERIALS AND METHODS

C u l t u r e C o n d i t i o n s
All procedures were approved by University of Alaska Fairbanks' Institutional Animal Care and Use Committee. Balb C male adult mice were euthanized by cervical dislocation and decapitation. Brains were removed and placed in 10°C oxygenated ar tificial cerebrospinal fluid (ACSF) consisting of: 124mM NaC1, 26mM NaHCO 3 , 1.2 mM NaH 2 PO 4 , 3.0mM KC1, 2.0mM MgSO 4 , 2.0mM CaC1 2 , and 10.0 mM D-glucose. Cor tex and striatum were trimmed coronally and affixed with cyanoacrylate to the mounting stage of a Camden vibroslice. Cor tical-striatal slices (350µm) were cut in cooled ACSF and then placed in six well plates containing 2.5mL ACSF. The well plates were placed on a rotomix in a 37°C oxygenated chamber set at 500 cc/minute compressed air (O 2 = 20%) and 10 cc/ minute CO 2 that maintained PO 2 at 80-100 mm Hg. After an initial recovery period of 30 minutes, H 2 O vehicle and NMDA (to final concentrations of 25µM, 50µM, 100µM) were added to the ACSF. Before diluting the melatonin to a final concentration, 5uL of methanol: water (1:1) was used in every preparation of melatonin to initially dissolve the solid. ACSF was then added to final volume; this methanol/CSF ratio was equal in every preparation, but methanol/melatonin levels were higher in the lower melatonin concentrations. A methanol control was performed along with the water control and showed no difference in oxidative stress. After 30 minutes, the ACSF was removed and fresh ACSF or melatonin (100µM or 1mM) -ACSF was added. Slices were allowed to recover for 5 hours. Melatonin was added to the slices following NMDA exposure because melatonin is thought to protect tissue from excitotoxins both during exposure and after when intracellular calcium levels have been increased. Therefore, the tissue slices were exposed to a further 5 hours of melatonin during the "recovery" phase while the NMDA alone, or controls were not.
Slices were fixed in methacarn (60% methanol, 30% chloroform and 10% glacial acetic acid) for 24 hours before immunocytochemical analysis. Slices were then placed between sheets of Goody ® permanent wave paper and embedded in paraffin. Five micron sections were taken using a microtome and placed on slides.
R e d o x a c t i v e i r o n a s s a y
As previously described (Smith et al, 1997) , sections were deparaffinized and stained with 7% K 4 Fe(CN) 6 (Sigma) in 3% HC1 overnight at room temperature. Sections were rinsed and developed with 0.075% 3,3-diaminobenzidine (DAB) with 3% H 2 O 2 for approximately 2 minutes. Sections were then dehydrated in an increasing ethanol series and mounted with xylene based mounting medium.
I m m u n o a s s a y s
Immunoasays were performed as previously described by Smith et al. (1994 Smith et al. ( , 1997 Smith et al. ( , 1998 and Nunomura et al. (1999) . Sections were deparaffinized and 10% normal goat serum (NGS) (Sigma) in Tris-buffered saline was added for 10 minutes. Primary antibody (rabbit antibody) to HO-1 (StressGen, Victoria, BC, Canada.) and 8-OHG (TreviGen, Gaithersburg, MD) was applied in 1% NGS at ratios of 1:1000 and 1:30, respectively, overnight at 4°C. Sections were rinsed with 1% NGS and nonspecific binding was blocked by the addition of 10% NGS for 10 minutes. Secondary goat anti-rabbit antibody was applied in 1% NGS at 1:50 for 30 minutes at room temperature. Sections were then rinsed and exposed to peroxidase antiperoxidase (PAP) complex (1:250 in 1% NGS) for 1 hour at room temperature. Sections were then rinsed in 1% NGS and dehydrated in an increasing ethanol series before mounting in xylene based mounting medium.
A n a l y s i s
Sections were visualized on a Zeiss Axiover t S100 microscope at 20X magnification. Four random fields per section using Zeiss software with set positive and negative thresholds were analyzed. Counts of positively stained cells were made by computer and averaged with doubleblind counts performed at Case Western Reserve University. Photomicrographs have been published previously (Clapp, 2000) . ANOVA was performed on cresyl violet counts to determine significance between groups. Posthoc t-tests were performed following ANOVAs. KruskalWallis single factor non-parametric analysis was performed on HO-1 and 8-OHG counts due to multiple zero values.
RESULTS
Cresyl violet stained sections of melatonin (100 µM) without NMDA showed positive nuclei numbers similar to control slices. Slices incubated in 100µM NMDA revealed a significant (p<0.001) increase in nuclei containing condensed chromatin (Fig. 1) . The addition of 100µM melatonin to NMDA-insulted slices significantly (p<0.001) decreased the appearance of condensed chromatin to near control levels. The observation of damaged chromatin by NMDA treatment was supported at the molecular level. An assay for oxidatively damaged nucleic acid species using an antibody to 8-OHG, the product of ROS and guanosine, indicated that 100µM NMDA caused a significant increase (p<0.0001) in NMDA induced 8-OHG immunoreactivity (Fig. 2) . The 8-OHG immunoreactivity of cells exposed to 100µM NMDA was significantly decreased (p<0.001) by the co-addition of 100µM melatonin. High concentration of melatonin (1mM) alone did not cause a significant increase in 8-OHG levels.
A biomarker of oxidative stress, HO-1 induction, indicated an increase in ROS by melatonin alone (Fig. 3) . Although HO-1 immunoreactivity following 100µM NMDA exposure was significantly decreased (p<0.005) by the coaddition of 100µM melatonin, 1mM melatonin alone without NMDA significantly increased (p<0.005) the amount of HO-1 reactivity as compared to control. This result shows that 1mM level of melatonin by itself can affect the vulnerability to oxidative stress.
The presence of redox active iron is also a useful biochemical marker of potential oxidative stress. The increase in redox active iron caused by the addition of 100µM NMDA was significantly attenuated (p<0.001) by the coaddition of 100µM melatonin (Fig 4) . However, in contrast to the results shown in Figures 1 and 2 , when 1mM melatonin, alone without NMDA, was added to the cultured slices, a significant increase (p< 0.001) in redox active iron was evident.
DISCUSSION
The present results show, for the first time, an effect of 1mM melatonin alone on redox active iron and HO-1 induction. While the data further confirm neuroprotective effects of melatonin (Wakatsuki et all, 1999; Kim and Kwon, 2000) , our result in NMDA stressed cells also emphasize that the margin of safety associated with therapeu- tic application of this endogenous antioxidant may not be as large as once imagined. In this study, we report the effects at only two concentrations because there was no protective effect observed until 100µM melatonin and no significant pro-oxidant effect until 1mM.
At 100 µM, melatonin exhibited antioxidant characteristics by protecting cells from 100µM NMDA induced oxidative stress. Melatonin (100µM) reduced damage to chromatin and DNA caused by NMDA (50-100µM) as evidenced by the reduction in cresyl-positive nuclei (Fig.1 ) and 8-OHG immunoreactivity (Fig. 2) . These results suggest that melatonin blocks NMDA-induced oxidative stress prior to its effect upon the nucleus.
To determine the effect of melatonin on cytoplasmic ROS after NMDA insult, we tested for redox active iron presence and HO-1 induction following NMDA treatment. Melatonin (100µM) reduced the induction of the endogenous antioxidant HO-1 following NMDA exposure (Fig. 3) . Melatonin (100µM) also significantly reduced the amount of redox-active iron expected following NMDA (50-100µM) insult (Fig. 4) . These results suppor t the conclusion that an antioxidant mechanism attenuates oxidative stress caused by NMDA exposure.
When high concentrations of melatonin (1mM) were added to cultured brain slices without NMDA, biomarkers of increased vulnerability to oxidative stress, i.e. an increase in redox active iron (Fig. 4) and HO-1 immunoreactivity (Fig. 3) , were induced. Interestingly, we did not observe morphological signs of oxidative stress (Clapp, 2000) or evidence of chromatin and DNA damage (Figs 1 and 2 ) following slice incubation with only high melatonin (1mM). This suggests that 1mM melatonin can induce these selected markers of oxidative stress that are usually considered to indicate pro-oxidant proper ties, but this induction does not negatively impact the morphology of the neurons during the short time period of the experiment. Organotypic brain slice preparation approximates in vivo conditions better than primary neuronal culture, and allows for more precise manipulation of NMDA concentrations than in vivo models. This study, using a culture system at physiological oxygen par tial pressure, revealed that 100µM melatonin was protective against NMDA-induced oxidative stress. In this initial study, the 100µM melatonin exceeded normal extracellular plasma concentrations of melatonin (approximately 0.5nM (Levine et al., 1994) ), but was similar or lower than those concentrations often used in other in vitro cell culture model systems (Cazevieille, et al., 1997; Lezoualc'h et al., 1996) . Our results in a slice culture system confirm recent in vivo studies in stroke models which repor ted that melatonin protects neurons from NMDA, kainate and quinolinic acid (Kim and Kwon, 1999; Cabrera et al., 2000) , and also suggest that the altered melatonin homeostasis, which occurs at extreme latitudes, may effect survival and recovery from stroke.
